GMPS, a crucial enzyme of de novo purine biosynthesis, has been identified as an important p53 repression target by proteomic analysis, and its up-regulation led to disruption of tumor-suppressive p53 network in liver cancer [33]. The gene discussed is TP53; the disease is neoplasm.